Context Therapeutics Inc. — Director's Dealing 2025

Jun 10, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Context Therapeutics Inc. (CNTX)
CIK: 0001842952
Period of Report: 2025-06-06

Reporting Person: Levit Alex C. (Chief Legal Officer, Corp. Sec)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-06-06	Common Stock	P	20000	$0.576	Acquired	29000	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	52983	Indirect

Footnotes

F1: The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.56 - $0.58. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.